ダウンロード数: 474
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
15_0460.pdf | 643.05 kB | Adobe PDF | 見る/開く |
タイトル: | Urocalunの上部尿路結石に対する排石効果の検討 (二重盲検法による同時対照実験) |
その他のタイトル: | Urocalun for upper urinary stones--investigation of its effect on stone passage by means of simultaneous control study in double blind method |
著者: | 加藤, 篤二 高橋, 陽一 福山, 拓夫 岡, 直友 長谷川, 辰寿 多田, 茂 森, 幸夫 |
著者名の別形: | Kato, Tokuji Takahashi, Youichi Fukuyama, Takuo Oka, Naotomo Hasegawa, Tatsuji Tada, Shigeru Mori, Yukio |
キーワード: | Adolescent Adult Clinical Trials as Topic Female Humans Male Middle Aged Placebos Plant Extracts/therapeutic use Plants Time Factors Urinary Calculi/drug therapy |
発行日: | Jun-1969 |
出版者: | 京都大学医学部泌尿器科学教室 |
誌名: | 泌尿器科紀要 |
巻: | 15 |
号: | 6 |
開始ページ: | 460 |
終了ページ: | 470 |
抄録: | "Urocalun" is a new drug for urolithiasis, and its main ingredient is the extract from Quercus stenophylla Makino. Its effect on stone passage was investigated by means of control study using placebo in a double blind method. Cumulative percentage of the population who passed stone was significantly greater in the Urocalun group than in the placebo group at any time of the course of this study. It was, therefore, proved that Urocalun was useful in discharging upper urinary tract calculi. As to medication other than Urocalun or placebo, there was no difference between two groups. Also, no difference was observed on the population who were lost from the follow-up study. No side effect attributed to Urocalun was experienced. Clinico-pharmacological study in double blind method such as adopted in this report is worthy to be recommended, because this can eliminate the subjective judgment. |
URI: | http://hdl.handle.net/2433/120007 |
PubMed ID: | 4897651 |
出現コレクション: | Vol.15 No.6 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。